Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
Aim. To study the effect of azilsartan medoxomil (AZL-M) on the 24-hour blood pressure (BP) profile in patients with hypertension (HTN), type 2 diabetes (T2D) and stable coronary artery disease (CAD).Material and methods. A total of 183 patients with CAD in combination with HTN and T2D took part in...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Столичная издательская компания
2023-11-01
|
| Serie: | Рациональная фармакотерапия в кардиологии |
| Soggetti: | |
| Accesso online: | https://www.rpcardio.online/jour/article/view/2948 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|